The MRL/lpr model of SLE resembles human lupus in its various immunopa
thologic characteristics including the presence of high-level Ige and
anti-DNA antibody production and multisystem organ involvement (nephri
tis, arthritis, and vasculitis). Our previous studies have shown that
IL-1 overactivity in B cells plays a potentially important role in dri
ving IgG and autoantibody production. However, the underlying mechanis
ms determining IL-1 overactivity are poorly understood. We studied IL-
1 beta gene expression and transcriptional rates in B cells derived fr
om old and young MRL/lpr, MRL/+ +, and non-autoimmune control mice usi
ng semi-quantitative RT-PCR and the nuclear run-on assay. RT-PCR demon
strated increased steady-state IL-1 beta gene expression in B cells de
rived from old MRL/lpr mice as compared to either young MRL/lpr or con
trol mice. Furthermore, IL-1 beta gene expression in B cells was assoc
iated with the presence of the lpr mutation because heightened IL-1 be
ta message was observed in RNA obtained from MRL/lpr but not MRL/+ + B
cells, IL-1 beta transcriptional rates measured by the nuclear run-on
assay were very similar in B cells from old and young MRL/lpr and con
trol mice. These observations suggest that IL-1 overactivity in B cell
s obtained from old diseased MRL/lpr results from heightened IL-1 beta
message, is associated with the presence of the lpr mutation, and is
likely to reflect post-transcriptional stabilization of IL-1 beta mRNA
.